Full text is available at the source.
Abstract
In the study, gadolinium-based contrast agents (GBCAs) showed marked contrast enhancement in control rats, indicating solute transition into the brain parenchyma.
- Ten male Wistar ST rats were used to analyze the role of aquaporin-4 (AQP4) in solute dynamics in the brain.
- Dynamic contrast-enhanced magnetic resonance imaging (dyMRI) revealed significant differences in GBCA distribution between control rats and those treated with the AQP4 inhibitor TGN-020.
- Control rats exhibited strong contrast enhancement over time, indicating effective GBCA distribution in various brain regions.
- Rats treated with TGN-020 showed reduced signal enhancement, suggesting impaired GBCA distribution due to AQP4 inhibition.
- The findings indicate a link between AQP4 function and the movement of solutes from cerebrospinal fluid into the brain's extracellular space.
Simplified